Archives
-
Pregnenolone Carbonitrile: PXR Research Workflows
2026-08-24
Pregnenolone Carbonitrile is a practical rodent PXR probe for connecting CYP3A-mediated xenobiotic clearance with cholestatic injury and fibrosis workflows. This guide translates published PCN dosing into reproducible assay design, sample handling, and troubleshooting decisions.
-
KNUCKLES Integrates Hormones in Floral Meristem Termination
2026-08-23
This Arabidopsis study identifies KNUCKLES as a chromatin-linked regulator that coordinates auxin distribution and cytokinin activity during floral meristem termination. By connecting repression of PIN1 and IPT7 with disruption of the WUS–CLV3 stem-cell circuit, the work provides a mechanistic explanation for how floral determinacy is timed.
-
Neuroligin 1 Loss Drives D2-MSN Repetitive Behavior
2026-08-22
This study identifies Neuroligin 1 deficiency in striatal dopamine D2 receptor-expressing medium spiny neurons as a cell-type-specific driver of excessive self-grooming and digging in mice. By combining behavioral analysis, D2-MSN activity manipulation, single-nucleus RNA sequencing, and protein validation, the work links neuronal hyperactivation and PKC overactivity to autistic-like repetitive behavior.
-
UTP Solution for Precision RNA Workflows
2026-08-21
UTP Solution (100 mM) supports reproducible in vitro transcription, RNA amplification, and siRNA synthesis with a high-purity, nuclease-free nucleotide source. This article connects practical RNA workflows to new mechanistic insights into TRIM66-dependent olfactory receptor regulation while clearly separating established evidence from assay recommendations.
-
Lipid-Like Nanoassemblies for Secreted ACE2 mRNA
2026-08-21
The reference study developed lipid-like nanoassemblies that protected in-vitro-transcribed mRNA, enabled high systemic translation, and produced secreted truncated ACE2 decoys with SARS-CoV-2 receptor-blocking activity. Its main contribution is a preclinical delivery strategy that connects combinatorial lipid design with transient production of an antiviral protein mimic.
-
Synthetic Receptor Microglia for Alzheimer’s Therapy
2026-08-20
Shao and colleagues developed a synthetic efferocytic receptor that redirects microglia toward amyloid-β clearance while preserving anti-inflammatory signaling. Delivered as mRNA lipid nanoparticles, the receptor improved amyloid handling, reduced inflammation and synapse loss, and improved behavioral outcomes in an Alzheimer’s disease mouse model.
-
2-Thio-dCTP and the Next Era of DNA Precision
2026-08-20
A mechanistic and translational guide to using 2-Thio-dCTP as a compact DNA perturbation tool, with practical strategies inspired by new SCP4 chromosome-stability findings.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-08-19
Li and colleagues developed fluoroalkane-grafted polyethylenimine (F-PEI) as a simple cationic carrier that combines mRNA protection and intracellular delivery with deliberate TLR4-mediated immune stimulation. In mouse models, F-PEI–mRNA vaccines improved dendritic-cell activation and antigen presentation, delayed B16-OVA melanoma, and, with checkpoint blockade, suppressed MC38 tumors and recurrence.
-
Pseudo-UTP for Better mRNA Synthesis Workflows
2026-08-19
Learn how Pseudo-UTP supports pseudouridine-containing RNA production, from in vitro transcription screening to translation and stability assays. This practical guide connects nucleotide substitution decisions with vaccine, gene therapy, and troubleshooting workflows while distinguishing product-level benefits from evidence in a preclinical vaccine study.
-
Deferasirox Pharmacokinetics and Clinical Evidence
2026-08-18
Galanello, Campus, and Origa synthesize pharmacokinetic, pharmacodynamic, efficacy, and safety evidence for deferasirox across transfusion-dependent anemias. The review’s central contribution is to connect oral chelation, iron-burden biology, adherence, and monitoring requirements while showing why treatment response varies between patient groups.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA while preserving a practical path from cell-based screening to in vivo imaging. This guide connects transcript handling, transfection, LNP formulation, normalization, and troubleshooting to evidence-based assay design.
-
Firefly Luciferase mRNA: Workflow & Optimization
2026-08-17
Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, transient readout for transfection, gene expression, cell viability, and delivery studies. This practical guide connects reporter assay design with emerging nanoparticle workflows, including lung-directed formulations and stability testing.
-
Betaine-Loaded LNPs Improve mRNA Delivery After Freezing
2026-08-17
The reference study shows that freeze concentration can be used not only to protect lipid nanoparticles (LNPs), but also to drive betaine incorporation into them during freeze–thaw processing. The incorporated betaine improves endosomal escape and mRNA delivery, producing stronger reporter expression and immune responses in mouse studies.
-
Methicillin Sodium Salt for MSSA Research
2026-08-16
Methicillin sodium salt provides a practical phenotypic benchmark for MSSA susceptibility, cell-wall biology, and resistance-aware assay design. This guide shows how to build reproducible dilution workflows, distinguish true MRSA resistance from technical failure, and translate results without overstating clinical relevance.
-
Firefly Luciferase mRNA Workflow Guide
2026-08-15
Build sensitive, reproducible reporter assays with Cap1-capped, 5-moUTP modified mRNA for delivery, translation, viability, and imaging studies. The workflow also shows how PEG-lipid selection can change LNP performance, helping researchers separate transcript quality from delivery effects.